COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS
The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that compr...
Saved in:
| Main Authors | , , , , , , , |
|---|---|
| Format | Patent |
| Language | English Spanish |
| Published |
19.07.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin.
La presente invención proporciona usos de un agonista del receptor de péptido 1 similar a glucagón, en combinación con metformina. Los usos incluyen tratar la diabetes tipo 2, reducir la glucosa sanguínea y mejorar la efectividad terapéutica de la metformina. La invención también proporciona composiciones farmacéuticas que comprenden un agonista de GLP1R y metformina. |
|---|---|
| AbstractList | The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin.
La presente invención proporciona usos de un agonista del receptor de péptido 1 similar a glucagón, en combinación con metformina. Los usos incluyen tratar la diabetes tipo 2, reducir la glucosa sanguínea y mejorar la efectividad terapéutica de la metformina. La invención también proporciona composiciones farmacéuticas que comprenden un agonista de GLP1R y metformina. |
| Author | Dharma Rao POLISETTI James C. QUADA, JR Thomas Scott YOKUM Bradley Alan CLARK Robert Carl ANDREWS Stephen Thomas DAVIS Maria Carmen VALCARCE LOPEZ Adnan M.M. MJALLI |
| Author_xml | – fullname: James C. QUADA, JR – fullname: Stephen Thomas DAVIS – fullname: Thomas Scott YOKUM – fullname: Adnan M.M. MJALLI – fullname: Maria Carmen VALCARCE LOPEZ – fullname: Dharma Rao POLISETTI – fullname: Bradley Alan CLARK – fullname: Robert Carl ANDREWS |
| BookMark | eNqFjM0OgjAQhHvQg3-vYPYFPCix8VpggSa2S9ol0RMhpp4MkGB8foF49zQzX2ZmLRZt14aV-CRkYm0Va7IeKAMF-bU8OlA5We0ZlE3BIGfkjLZzqjwCF-hwbI948sAOFRu0PF3wvUQ4QapVjIx-HtG0GJEnl6LzW7F8Nq8h7H66EfsMOSkOoe_qMPTNI7ThXZtbJKW8nOPob-EL2NQ5dQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMBINACIONES DE UN AGONISTA DE GLP1R Y METFORMINA, Y USO DE LOS MISMOS PARA EL TRATAMIENTO DE LA DIABETES TIPO 2 Y OTROS TRASTORNOS. |
| ExternalDocumentID | MX366685B |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_MX366685B3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:00:30 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Spanish |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_MX366685B3 |
| Notes | Application Number: MX20150008555 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190719&DB=EPODOC&CC=MX&NR=366685B |
| ParticipantIDs | epo_espacenet_MX366685B |
| PublicationCentury | 2000 |
| PublicationDate | 20190719 |
| PublicationDateYYYYMMDD | 2019-07-19 |
| PublicationDate_xml | – month: 07 year: 2019 text: 20190719 day: 19 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | VTV THERAPEUTICS LLC |
| RelatedCompanies_xml | – name: VTV THERAPEUTICS LLC |
| Score | 3.068199 |
| Snippet | The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190719&DB=EPODOC&locale=&CC=MX&NR=366685B |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2VgoAblH2pfEC9RWRpk3KIUBanDSKLEheFU0UaB3FpKxrg9xmHFLj0Zo_tkTzS83hszzPAzQxdSvGiDiWDy7LU5wJSsl5IeamVijbAui6ykYNQH0_6D9kga8HrOhem5gn9qskREVEzxHtVr9fLv0Mst35bubrN31C0uPeY6faa6Bi9m4EIdG2TxpEbOT3HMYOsFyamhtv04cDegm3BuSVI9umTLVJSlv_9iXcAOzGqmleH0OKrDuw562_XOrAbNLfdWGyAtzqCTycKbP-HujYlkUcsMnqMlYRYoyj0U0as0CUBZRjTBX5Y1yYpJWxME4q9USzKhCXUYoK-X6hgzzElKnF9y6aMpvWgSIxAUYqxIU3SY-h6lDljCScw_TXVNMiaiWon0J4v5vwMiKIbhV5wVc813ueqil1LeVYikI0SDcbP4XSDkouNLZewL6wtDjmVuytoV-8f_Bq9c5V3a8t-A5Gmi7c |
| link.rule.ids | 230,308,780,885,25564,76547 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDI7GQIwbjPdj5IB2q-hja8ehQn2ka2FpqzZD4zTRNUVctokV-Ps4pQMuuyWOYymWvjhOYhuhmxmYlPxFHUgGl2WpxwWkZD2XskIrFK0PfV1EI9NQ98e9h0l_0kCv61iYKk_oV5UcERA1A7yX1X69_LvEcqu_lavb7A1Ii3uPmW639o7BuhmAQNc2SRy5kdN1HJNOumFianBMH_TtLbRtiHK74tz0ZIuQlOV_e-Lto50YRM3LA9TgqzZqOeuya220S-vXbmjWwFsdok8nonbwk7o2xZGHLTwcxUqCrWEUBinDVuhiShj4dDQIq944JZj5JCHADWTRxiwhFhPp-4UI9hwTrGI3sGzCSFpNisQMIKXgG5IkPUIdjzDHl2AB019VTemkXqh2jJrzxZyfIqzoRq7nXNUzjfe4qgJrIc8KALJRgML4GTrZIOR848g1avmMjqajIHy8QHtC8-LCU7m7RM3y_YNfgaUus06l5W9I3Y6o |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATIONS+OF+A+GLP1R+AGONIST+AND+METFORMIN+AND+USE+THEREOF+FOR+THE+TREATMENT+OF+TYPE+2+DIABETES+AND+OTHER+DISORDERS&rft.inventor=James+C.+QUADA%2C+JR&rft.inventor=Stephen+Thomas+DAVIS&rft.inventor=Thomas+Scott+YOKUM&rft.inventor=Adnan+M.M.+MJALLI&rft.inventor=Maria+Carmen+VALCARCE+LOPEZ&rft.inventor=Dharma+Rao+POLISETTI&rft.inventor=Bradley+Alan+CLARK&rft.inventor=Robert+Carl+ANDREWS&rft.date=2019-07-19&rft.externalDBID=B&rft.externalDocID=MX366685B |